Home > Boards > US OTC > Medical - Healthcare >


Add SPHRY Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 2/12/2021 2:20:29 PM - Followers: 8 - Board type: Free - Posts Today: 0

Starpharma at a glance: Starpharma is a world leader in the development of dendrimer nanotechnology-based products for pharmaceutical and life sciences. It is based in Melbourne, Australia and employs approximately 36 staff. Dendritic Nanotechnologies Inc (DNT) is a wholly owned subsidiary based in Michigan, USA. It has approximately 16 staff. Starpharma's lead product, VivaGel™, is a gel-based microbicide under development for the prevention of HIV infection and genital herpes. The potential market for microbicides has been estimated at greater than a billion dollars annually. The current incidence of HSV-2 (genital herpes) is estimated at 15-25% of the adult population in industrialised nations. This is forecast to rise substantially over the next decade. There is currently no cure for genital herpes. Prevention is the only way to deal with the risk of infection. There are currently 40 million people living with HIV and 7,000 women are infected each day. The US Government estimates that by age 25, half of all sexually active people in the US can expect to be infected with an STI. More than 50 attempts to develop an HIV vaccine have failed. Expert opinion is that it will most likely be many years before such a vaccine becomes available, if it ever does. VivaGel™ has shown good efficacy against HIV and HSV-2 in rigorous in vivo animal testing. VivaGel™ has completed a Phase I clinical trial and was recently granted Fast Track status by the US FDA as a product for prevention of HIV infection, accelerating the development of VivaGel™. VivaGel™ has external development funding for both its HIV and HSV-2 indications. In 2005 the US-based NIH provided $26 million of non-diluting funding and significant support in the global development of VivaGel™ for HIV prevention. In 2006 the NIH provided additional funding support for the development of the HSV-2 indication, again without loss of product ownership by Starpharma. VivaGel™ has a number of line extensions in development including condom coating and a gel with additional contraceptive properties. The broader dendrimer pipeline provides Starpharma with multiple market opportunities in the fields of cancer, cardiology, ophthalmic medicine, GPCR targeting drugs and ADME engineering™. US-based subsidiary DNT is developing nano-molecules for a range of life science and industrial applications. DNT has a broad and comprehensive IP portfolio of approximately 180 patents/applications issued and pending. DNT has existing revenue streams from licensing deals with leading pharmaceutical and biotechnology companies including Pfizer Inc. and Sigma Aldrich.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#155   NOW Sphry hitting 18..Up and AWAY Again PEACHMAN 02/12/21 02:20:29 PM
#154   now hitting 16 up up and away PEACHMAN 02/10/21 02:14:31 PM
#153   KABOOM SPHRY over 14 now PEACHMAN 02/05/21 07:31:59 PM
#152   SPHRY 12.62 and rising PEACHMAN 12/29/20 12:02:55 PM
#150   Peachman still making money as SPHRY keeps rising PEACHMAN 09/14/20 02:18:11 PM
#149   Another good day at STARPHAMA 11.65 PEACHMAN 09/09/20 04:20:14 PM
#148   SPHRY up again over 10.50 PEACHMAN 08/27/20 12:44:26 PM
#147   sphry still going up PEACHMAN 08/25/20 12:34:20 PM
#146   MORE SPHRY NEWS PEACHMAN 07/08/20 08:12:31 PM
#145   More SPHRY news. PEACHMAN 06/17/20 08:58:18 AM
#144   SPHRY climbing upward PEACHMAN 05/21/20 02:24:15 PM
#143   Loading up shares of SPHRY under 8 in PEACHMAN 02/20/20 09:54:22 AM
#142   NEW Starpharma update PEACHMAN 02/10/20 07:23:18 PM
#141   new Starphama update OcT 1 PEACHMAN 10/01/19 06:03:21 PM
#140   New Starphama update PEACHMAN 08/14/19 08:58:45 PM
#139   August update on Starphama PEACHMAN 08/07/19 09:26:54 PM
#138   July update on SPHRY PEACHMAN 07/01/19 07:19:54 AM
#137   More Great news SPHRY PEACHMAN 06/27/19 11:07:40 AM
#136   SPHRY presenting in Melbourne PEACHMAN 06/19/19 11:14:05 PM
#135   More Great news today at SPHRY PEACHMAN 06/11/19 09:47:34 PM
#134   Everyday new news on SPHRY PEACHMAN 06/03/19 10:34:06 PM
#133   More news on SPHRY today PEACHMAN 06/03/19 10:50:06 AM
#132   More news on SPHRY May 29th PEACHMAN 05/28/19 09:34:45 PM
#131   Not going to see pps under 9 much PEACHMAN 05/25/19 09:30:12 AM
#130   Starphama presents at Macquarie Australia Conference PEACHMAN 04/30/19 09:34:47 PM
#129   Another STARPHARMA update should cause increase in pps PEACHMAN 04/16/19 09:12:52 AM
#128   Starpharma update PEACHMAN 04/11/19 09:55:46 AM
#127   Educate yourself buy Starpharma and hold PEACHMAN 04/07/19 04:28:00 PM
#126   Why not spend some time in learning why PEACHMAN 04/07/19 04:24:52 PM
#125   PPS keeps rising this month in anticipation of PEACHMAN 04/04/19 02:39:27 PM
#124   ›› FDA meeting to discuss VivaGel® BV PEACHMAN 03/27/19 04:24:34 PM
#123   New meeting in Mid April for Starphama with PEACHMAN 03/27/19 02:47:04 PM
#122   New news on STARPHAMA SPHRY https://starpharma.com/news/395 PEACHMAN 12/20/18 12:31:05 PM
#121   On the phone now with a stock broker 4u2nv2 04/18/18 09:30:28 PM
#120   sorry I bought some shares but I wish PEACHMAN 02/04/18 11:08:23 AM
#119   I wish I did not buy more from PEACHMAN 02/03/18 12:53:26 PM
#118   i wish I didn't sell half to buy Michael Scofield 01/31/18 11:23:49 AM
#117   Nice to see that we were correct 2 PEACHMAN 01/30/18 09:02:16 AM
#116   Starpharma will be at 15 by Christmas. I PEACHMAN 09/28/17 04:03:01 PM
#115   Starpharma just getting started PEACHMAN 09/08/17 07:02:00 AM
#114   wow two years already PEACHMAN 08/11/17 01:49:25 PM
#113   Great news today pps keeps going higher PEACHMAN 01/12/17 03:40:25 PM
#112   I love it when it keep going higher PEACHMAN 11/08/16 04:07:01 PM
#111   SPHRY GOING HIGHER PEACHMAN 10/27/16 04:37:09 PM
#110   http://www.thestreet.com/story/13498233/1/adama-licenses-starpharmas-priostar-de Michael Scofield 03/31/16 02:00:23 PM
#109   Nice gain today for SPHRY PEACHMAN 11/16/15 08:59:12 PM
#108   http://www.4-traders.com/STARPHARMA-HOLDINGS-LIMIT-8864716/news/Starpharma--Appe Michael Scofield 11/09/15 02:53:53 PM
#107   SPHRY has very little volume and needs awareness PEACHMAN 10/17/15 11:02:40 AM
#106   Hopefully this company will start getting some looks Michael Scofield 10/17/15 07:05:03 AM
Consent Preferences